Excelimmune Garners $1,000,000 Series B Financing Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    12-B Cabot Road Woburn, MA 01801
  • Company Description
    Excelimmune Inc., based in Cambridge, is a biotechnology company developing therapuetic applications of human recombinant polyclonal antibodies.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds from the financing will be used to continue studies of the company’s first drug candidate, Staphguard, a human recombinant polyclonal antibody (HRPA) against methicillin-resistant Staphylococcus aureus (MRSA).
  • M&A Terms
  • Venture Investor

Trending on Xconomy